PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Yang, L. ; Gradl, R.* ; Dierolf, M.* ; Möller, W. ; Kutschke, D. ; Feuchtinger, A. ; Hehn, L.* ; Donnelley, M.* ; Günther, B.* ; Achterhold, K.* ; Walch, A.K. ; Stöger, T. ; Razansky, D. ; Pfeiffer, F.* ; Morgan, K.S.* ; Schmid, O.

Multimodal precision imaging of pulmonary nanoparticle delivery in mice: Dynamics of application, spatial distribution, and dosimetry.

Small 15:1904112 (2019)
Postprint DOI PMC
Open Access Green
Targeted delivery of nanomedicine/nanoparticles (NM/NPs) to the site of disease (e.g., the tumor or lung injury) is of vital importance for improved therapeutic efficacy. Multimodal imaging platforms provide powerful tools for monitoring delivery and tissue distribution of drugs and NM/NPs. This study introduces a preclinical imaging platform combining X-ray (two modes) and fluorescence imaging (three modes) techniques for time-resolved in vivo and spatially resolved ex vivo visualization of mouse lungs during pulmonary NP delivery. Liquid mixtures of iodine (contrast agent for X-ray) and/or (nano)particles (X-ray absorbing and/or fluorescent) are delivered to different regions of the lung via intratracheal instillation, nasal aspiration, and ventilator-assisted aerosol inhalation. It is demonstrated that in vivo propagation-based phase-contrast X-ray imaging elucidates the dynamic process of pulmonary NP delivery, while ex vivo fluorescence imaging (e.g., tissue-cleared light sheet fluorescence microscopy) reveals the quantitative 3D drug/particle distribution throughout the entire lung with cellular resolution. The novel and complementary information from this imaging platform unveils the dynamics and mechanisms of pulmonary NM/NP delivery and deposition for each of the delivery routes, which provides guidance on optimizing pulmonary delivery techniques and novel-designed NM for targeting and efficacy.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
10.856
1.593
12
16
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Aerosol Inhalation Therapy ; Lung Fluorescence Imaging ; Optical Tissue Clearing ; Pulmonary Delivery ; X-ray Imaging; Targeted Delivery; Drug; Particle; Biodistribution; Translocation; Inhalation; Deposition; Advantages; Pollutant
Sprache englisch
Veröffentlichungsjahr 2019
HGF-Berichtsjahr 2019
ISSN (print) / ISBN 1613-6810
e-ISSN 1613-6829
Zeitschrift Small
Quellenangaben Band: 15, Heft: 59, Seiten: , Artikelnummer: 1904112 Supplement: ,
Verlag Wiley
Verlagsort Postfach 101161, 69451 Weinheim, Germany
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Lung Health and Immunity (LHI)
Research Unit Analytical Pathology (AAP)
CF Pathology & Tissue Analytics (CF-PTA)
Institute of Biological and Medical Imaging (IBMI)
POF Topic(s) 30202 - Environmental Health
30205 - Bioengineering and Digital Health
30505 - New Technologies for Biomedical Discoveries
Forschungsfeld(er) Lung Research
Enabling and Novel Technologies
PSP-Element(e) G-505000-008
G-505000-001
G-500390-001
A-630600-001
G-505590-001
DOI 10.1002/smll.201904112
WOS ID WOS:000494148900001
Scopus ID 85074643566
PubMed ID 31639283
Erfassungsdatum 2019-10-24
[➜Korrektur melden]